![Anthony Smithyman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony Smithyman
Chief Executive Officer at Special Phage Holdings Pty Ltd.
Anthony Smithyman active positions
Companies | Position | Start | End |
---|---|---|---|
Special Phage Holdings Pty Ltd.
![]() Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Special Phage Holdings Pty Ltd. operates as a holding Australian company with interests in phage therapy. The company is based in Neutral Bay, Australia. The company was founded by Anthony Smithyman. Anthony Smithyman has been the CEO since incorporation. Special Phage Holdings was acquired by AmpliPhi Australia Pty Ltd. on November 13, 2012 for $6.77 million. | Chief Executive Officer | 22/01/2014 | - |
Founder | 22/01/2014 | - | |
Cellabs Pty Ltd.
![]() Cellabs Pty Ltd. Medical/Nursing ServicesHealth Services Cellabs Pty Ltd. is a boutique diagnostics company based in Sydney that specializes in designing, developing, and manufacturing immunodiagnostic kits for tropical and infectious diseases. The Australian company's focus is on providing accurate and reliable diagnostic solutions to healthcare professionals and patients. The CEO of the private company is Anthony Smithyman. | Chief Executive Officer | - | - |
Career history of Anthony Smithyman
Former positions of Anthony Smithyman
Companies | Position | Start | End |
---|---|---|---|
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Director/Board Member | 31/10/2012 | 15/04/2015 |
Training of Anthony Smithyman
University of St. Andrews | Undergraduate Degree |
University of Glasgow | Doctorate Degree |
Statistics
International
United Kingdom | 3 |
Australia | 3 |
United States | 2 |
Operational
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Founder | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Special Phage Holdings Pty Ltd.
![]() Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Special Phage Holdings Pty Ltd. operates as a holding Australian company with interests in phage therapy. The company is based in Neutral Bay, Australia. The company was founded by Anthony Smithyman. Anthony Smithyman has been the CEO since incorporation. Special Phage Holdings was acquired by AmpliPhi Australia Pty Ltd. on November 13, 2012 for $6.77 million. | Health Technology |
Cellabs Pty Ltd.
![]() Cellabs Pty Ltd. Medical/Nursing ServicesHealth Services Cellabs Pty Ltd. is a boutique diagnostics company based in Sydney that specializes in designing, developing, and manufacturing immunodiagnostic kits for tropical and infectious diseases. The Australian company's focus is on providing accurate and reliable diagnostic solutions to healthcare professionals and patients. The CEO of the private company is Anthony Smithyman. | Health Services |
- Stock Market
- Insiders
- Anthony Smithyman
- Experience